| __timestamp | Takeda Pharmaceutical Company Limited | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 1256834000000 | 11503000 |
| Thursday, January 1, 2015 | 1271973000000 | 24698000 |
| Friday, January 1, 2016 | 1173296000000 | 26076000 |
| Sunday, January 1, 2017 | 1274610000000 | 33570000 |
| Monday, January 1, 2018 | 1437534000000 | 58697000 |
| Tuesday, January 1, 2019 | 2201424000000 | 80279000 |
| Wednesday, January 1, 2020 | 2203504000000 | 84228000 |
| Friday, January 1, 2021 | 2462160000000 | 106025000 |
| Saturday, January 1, 2022 | 2783406000000 | 109788000 |
| Sunday, January 1, 2023 | 2832257000000 | 135576000 |
| Monday, January 1, 2024 | 2832257000000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals and biotechnology, Takeda Pharmaceutical Company Limited and Vericel Corporation present a fascinating study in contrasts. Over the past decade, Takeda has consistently demonstrated robust growth, with its gross profit surging by approximately 125% from 2014 to 2023. This Japanese giant's financial prowess is evident, with its gross profit peaking at around 2.83 trillion yen in 2023.
Meanwhile, Vericel Corporation, a smaller player in the biotech sector, has shown impressive growth relative to its size. From 2014 to 2023, Vericel's gross profit increased nearly twelvefold, reaching approximately 136 million dollars. Despite its smaller scale, Vericel's growth trajectory highlights its potential in the regenerative medicine market.
This performance breakdown underscores the diverse strategies and market positions of these two companies, offering valuable insights into their financial health and future prospects.
Pfizer Inc. and Vericel Corporation: A Detailed Gross Profit Analysis
Sanofi and Vericel Corporation: A Detailed Gross Profit Analysis
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Takeda Pharmaceutical Company Limited and Incyte Corporation: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Vericel Corporation
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends
Key Insights on Gross Profit: Biogen Inc. vs Vericel Corporation
Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Vericel Corporation